… within pharma--including roles as Chief Executive Officer and Chief Medical Officer … as Chief Medical Officer for Chelsea Therapeutics (2009-2014), a Charlotte North … of neurogenic orthostatic hypotension; as CEO for Mateon Therapeutics (2015-2019 …

… G. Oliveto as President and Chief Executive Officer, effective immediately. His appointment … Oliveto served as President and CEO of Chelsea Therapeutics, a publicly held biopharmaceutical … of-joseph-g-oliveto-as-chief-executive-officer-300418760.html SOURCE …

… 11, 2009 (FinancialWire) — Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP) has … ’s president and CEO. “Top-line data …

… (FinancialWire) — Data from Chelsea Therapeutics International’s (NASDAQ … ’s president and chief executive officer, said, “Having …

… Oliveto, Milestone’s president and chief executive officer, said in an interview … his prior company, Charlotte-based Chelsea Therapeutics, was sold to the Danish …

… and CEO of Cellectar Biosciences, President and CEO of Chelsea Therapeutics and … vaccine offers,” said Pat Gallagher, Chief Executive Officer, Voltron Therapeutics, Inc. … experience building and selling Chelsea Therapeutics will help Voltron better position …

… ., M.B.A., President and Chief Executive Officer of Iovance. “Michael’s … founder and currently the co-CEO of Actin Biomed LLC, a … the board of directors of Chelsea Therapeutics International, Ltd., a development stage …

… ). The announcement of a new CEO could also be a stock … still looking for a new CEO to replace Kare Schultz, the … was acquired in the 2014 Chelsea Therapeutics deal. Only Trintellix has come … terms of finding a new CEO (and what that person wants …